Heart Lung Machine Market By Component (Oxygenator, Pump, Cannula, Monitoring System, Heat Exchange Unit, Blood Reservoir, Others) , By Application (Coronary Artery Bypass Grafting (CABG) , Heart Valve Surgeries, Heart Transplant, Lung Transplant, Others) By End User (Hospitals, Cardiac Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The global heart–lung machine market was valued at $2.3 billion in 2023, and is projected to reach $4.5 billion by 2033, growing at a CAGR of 6.7% from 2024 to 2033.
A heart–lung machine is a medical device used during open-heart surgery to temporarily take over the function of the heart and lungs. It maintains the circulation of blood and the oxygenation of the body when the heart is stopped or undergoing surgical intervention. This machine is essential in providing a stable blood flow, oxygenating the blood, and removing carbon dioxide from the body while the heart is not functioning. The heart–lung machine is equipped with a pump, an oxygenator, and a series of tubing to circulate blood throughout the body, ensuring that vital organs, especially the brain and kidneys, continue to receive an adequate supply of oxygen and nutrients during surgery.
The global heart–lung machine market is witnessing robust growth due to factors such as alarming rise in prevalence of cardiovascular diseases. According to a recent study published by the World Health Organization, cardiovascular diseases have been reported cause the largest disease burden worldwide, resulting in approximately 17.9 million deaths each year. This emphasizes the urgent need for advanced surgical solutions like heart–lung machines for life-saving procedures. In addition, surge in geriatric population acts as the key driving force of the global market. This is attributed to the fact that aged individuals are highly susceptible to heart-related conditions, resulting in a higher demand for surgical interventions involving heart-lung machines. A 2024 study published by the World Health Organization revealed that the number of aged individuals will increase from 1 billion in 2020 to 1.4 billion by 2030. Moreover, the number of individuals aging 80 years and older is estimated to reach 426 million by 2050. Furthermore, surge in procedures like coronary artery bypass grafting and valve replacements due to improved healthcare access and early diagnosis boosts the growth of the global market. Furthermore, rise in awareness about cardiovascular diseases, increase in availability of trained cardiothoracic surgeons, and supportive government funding for advanced medical technologies and favorable reimbursement scenarios in developed countries encourage the adoption of heart–lung machines, thus strengthening the market growth. However, complications associated with cardiopulmonary bypass, such as inflammatory responses, coagulation issues, and organ dysfunction, can pose significant risks, reducing the willingness of healthcare providers and patients to adopt the technology. Moreover, lack of adequate healthcare infrastructure acts as a key barrier to widespread adoption of these machines, thus limiting the market growth. On the contrary, innovations such as miniaturized and portable heart–lung machines, advanced oxygenators, and integrated monitoring systems enhance precision and reduce complications. Such developments are expected to open new avenues for the expansion of the global market during the forecast period.
The global heart–lung machine market is segmented into component, application, end user, and region. On the basis of component, the market is classified into oxygenator, pump, cannula, monitoring system, heat exchange unit, blood reservoir, and others. Depending on application, it is segregated into coronary artery bypass grafting, heart valve surgeries, heart transplant, lung transplant, and others. By end user, it is divided into hospitals, cardiac centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of component, the oxygenators segment is expected to dominate the market from 2024 to 2033.
Depending on application, the bypass grafting (CABG) segment is anticipated to exhibit the highest growth during the forecast period.
By end user, the hospitals segment is projected to grow at a notable pace in the near future.
Region wise, North America held the largest market share in terms of revenue in 2023, and is expected to dominate the market during the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global heart–lung machine market include Medtronic plc, Terumo Corporation, Getinge AB, Sorin Group., LivaNova PLC, Fresenius SE & Co. KGaA, Boston Scientific Corporation, Cardinal Health, Inc., Nipro Corporation, and Asahi Kasei Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the global market.
Additional benefits you will get with this purchase are:
By Component
A heart–lung machine is a medical device used during open-heart surgery to temporarily take over the function of the heart and lungs. It maintains the circulation of blood and the oxygenation of the body when the heart is stopped or undergoing surgical intervention. This machine is essential in providing a stable blood flow, oxygenating the blood, and removing carbon dioxide from the body while the heart is not functioning. The heart–lung machine is equipped with a pump, an oxygenator, and a series of tubing to circulate blood throughout the body, ensuring that vital organs, especially the brain and kidneys, continue to receive an adequate supply of oxygen and nutrients during surgery.
The global heart–lung machine market is witnessing robust growth due to factors such as alarming rise in prevalence of cardiovascular diseases. According to a recent study published by the World Health Organization, cardiovascular diseases have been reported cause the largest disease burden worldwide, resulting in approximately 17.9 million deaths each year. This emphasizes the urgent need for advanced surgical solutions like heart–lung machines for life-saving procedures. In addition, surge in geriatric population acts as the key driving force of the global market. This is attributed to the fact that aged individuals are highly susceptible to heart-related conditions, resulting in a higher demand for surgical interventions involving heart-lung machines. A 2024 study published by the World Health Organization revealed that the number of aged individuals will increase from 1 billion in 2020 to 1.4 billion by 2030. Moreover, the number of individuals aging 80 years and older is estimated to reach 426 million by 2050. Furthermore, surge in procedures like coronary artery bypass grafting and valve replacements due to improved healthcare access and early diagnosis boosts the growth of the global market. Furthermore, rise in awareness about cardiovascular diseases, increase in availability of trained cardiothoracic surgeons, and supportive government funding for advanced medical technologies and favorable reimbursement scenarios in developed countries encourage the adoption of heart–lung machines, thus strengthening the market growth. However, complications associated with cardiopulmonary bypass, such as inflammatory responses, coagulation issues, and organ dysfunction, can pose significant risks, reducing the willingness of healthcare providers and patients to adopt the technology. Moreover, lack of adequate healthcare infrastructure acts as a key barrier to widespread adoption of these machines, thus limiting the market growth. On the contrary, innovations such as miniaturized and portable heart–lung machines, advanced oxygenators, and integrated monitoring systems enhance precision and reduce complications. Such developments are expected to open new avenues for the expansion of the global market during the forecast period.
The global heart–lung machine market is segmented into component, application, end user, and region. On the basis of component, the market is classified into oxygenator, pump, cannula, monitoring system, heat exchange unit, blood reservoir, and others. Depending on application, it is segregated into coronary artery bypass grafting, heart valve surgeries, heart transplant, lung transplant, and others. By end user, it is divided into hospitals, cardiac centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of component, the oxygenators segment is expected to dominate the market from 2024 to 2033.
Depending on application, the bypass grafting (CABG) segment is anticipated to exhibit the highest growth during the forecast period.
By end user, the hospitals segment is projected to grow at a notable pace in the near future.
Region wise, North America held the largest market share in terms of revenue in 2023, and is expected to dominate the market during the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global heart–lung machine market include Medtronic plc, Terumo Corporation, Getinge AB, Sorin Group., LivaNova PLC, Fresenius SE & Co. KGaA, Boston Scientific Corporation, Cardinal Health, Inc., Nipro Corporation, and Asahi Kasei Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the global market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
- Additional company profiles with specific to client's interest
- Expanded list for Company Profiles
- Historic market data
By Component
- Oxygenator
- Pump
- Cannula
- Monitoring System
- Heat Exchange Unit
- Blood Reservoir
- Others
- Coronary Artery Bypass Grafting (CABG)
- Heart Valve Surgeries
- Heart Transplant
- Lung Transplant
- Others
- Hospitals
- Cardiac Centers
- Others
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
- Key Market Players
- Medtronic plc
- Terumo Corporation
- Getinge AB
- Sorin Group.
- LivaNova PLC
- Fresenius SE & Co. KGaA
- Boston Scientific Corporation
- Cardinal Health, Inc.
- Nipro Corporation
- Asahi Kasei Corporation
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: HEART LUNG MACHINE MARKET, BY COMPONENT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Component
4.2. Oxygenator
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Pump
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Cannula
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Monitoring System
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. Heat Exchange Unit
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
4.7. Blood Reservoir
4.7.1. Key Market Trends, Growth Factors and Opportunities
4.7.2. Market Size and Forecast, By Region
4.7.3. Market Share Analysis, By Country
4.8. Others
4.8.1. Key Market Trends, Growth Factors and Opportunities
4.8.2. Market Size and Forecast, By Region
4.8.3. Market Share Analysis, By Country
CHAPTER 5: HEART LUNG MACHINE MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Coronary Artery Bypass Grafting (CABG)
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Heart Valve Surgeries
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Heart Transplant
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Lung Transplant
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Others
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
CHAPTER 6: HEART LUNG MACHINE MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Cardiac Centers
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: HEART LUNG MACHINE MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Component
7.2.3. Market Size and Forecast, By Application
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Heart Lung Machine Market
7.2.6.1. Market Size and Forecast, By Component
7.2.6.2. Market Size and Forecast, By Application
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Heart Lung Machine Market
7.2.7.1. Market Size and Forecast, By Component
7.2.7.2. Market Size and Forecast, By Application
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Heart Lung Machine Market
7.2.8.1. Market Size and Forecast, By Component
7.2.8.2. Market Size and Forecast, By Application
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Component
7.3.3. Market Size and Forecast, By Application
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. France Heart Lung Machine Market
7.3.6.1. Market Size and Forecast, By Component
7.3.6.2. Market Size and Forecast, By Application
7.3.6.3. Market Size and Forecast, By End User
7.3.7. Germany Heart Lung Machine Market
7.3.7.1. Market Size and Forecast, By Component
7.3.7.2. Market Size and Forecast, By Application
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Italy Heart Lung Machine Market
7.3.8.1. Market Size and Forecast, By Component
7.3.8.2. Market Size and Forecast, By Application
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Spain Heart Lung Machine Market
7.3.9.1. Market Size and Forecast, By Component
7.3.9.2. Market Size and Forecast, By Application
7.3.9.3. Market Size and Forecast, By End User
7.3.10. UK Heart Lung Machine Market
7.3.10.1. Market Size and Forecast, By Component
7.3.10.2. Market Size and Forecast, By Application
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest Of Europe Heart Lung Machine Market
7.3.11.1. Market Size and Forecast, By Component
7.3.11.2. Market Size and Forecast, By Application
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Component
7.4.3. Market Size and Forecast, By Application
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. China Heart Lung Machine Market
7.4.6.1. Market Size and Forecast, By Component
7.4.6.2. Market Size and Forecast, By Application
7.4.6.3. Market Size and Forecast, By End User
7.4.7. Japan Heart Lung Machine Market
7.4.7.1. Market Size and Forecast, By Component
7.4.7.2. Market Size and Forecast, By Application
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Heart Lung Machine Market
7.4.8.1. Market Size and Forecast, By Component
7.4.8.2. Market Size and Forecast, By Application
7.4.8.3. Market Size and Forecast, By End User
7.4.9. South Korea Heart Lung Machine Market
7.4.9.1. Market Size and Forecast, By Component
7.4.9.2. Market Size and Forecast, By Application
7.4.9.3. Market Size and Forecast, By End User
7.4.10. Australia Heart Lung Machine Market
7.4.10.1. Market Size and Forecast, By Component
7.4.10.2. Market Size and Forecast, By Application
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Heart Lung Machine Market
7.4.11.1. Market Size and Forecast, By Component
7.4.11.2. Market Size and Forecast, By Application
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Component
7.5.3. Market Size and Forecast, By Application
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Heart Lung Machine Market
7.5.6.1. Market Size and Forecast, By Component
7.5.6.2. Market Size and Forecast, By Application
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa Heart Lung Machine Market
7.5.7.1. Market Size and Forecast, By Component
7.5.7.2. Market Size and Forecast, By Application
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Heart Lung Machine Market
7.5.8.1. Market Size and Forecast, By Component
7.5.8.2. Market Size and Forecast, By Application
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Heart Lung Machine Market
7.5.9.1. Market Size and Forecast, By Component
7.5.9.2. Market Size and Forecast, By Application
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Medtronic Plc
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Terumo Corporation
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Getinge AB
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Sorin Group.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. LivaNova PLC
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Fresenius SE And Co. KGaA
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Boston Scientific Corporation
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Cardinal Health, Inc.
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Nipro Corporation
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Asahi Kasei Corporation
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: HEART LUNG MACHINE MARKET, BY COMPONENT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Component
4.2. Oxygenator
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Pump
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Cannula
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Monitoring System
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. Heat Exchange Unit
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
4.7. Blood Reservoir
4.7.1. Key Market Trends, Growth Factors and Opportunities
4.7.2. Market Size and Forecast, By Region
4.7.3. Market Share Analysis, By Country
4.8. Others
4.8.1. Key Market Trends, Growth Factors and Opportunities
4.8.2. Market Size and Forecast, By Region
4.8.3. Market Share Analysis, By Country
CHAPTER 5: HEART LUNG MACHINE MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Coronary Artery Bypass Grafting (CABG)
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Heart Valve Surgeries
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Heart Transplant
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Lung Transplant
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Others
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
CHAPTER 6: HEART LUNG MACHINE MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Cardiac Centers
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: HEART LUNG MACHINE MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Component
7.2.3. Market Size and Forecast, By Application
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Heart Lung Machine Market
7.2.6.1. Market Size and Forecast, By Component
7.2.6.2. Market Size and Forecast, By Application
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Heart Lung Machine Market
7.2.7.1. Market Size and Forecast, By Component
7.2.7.2. Market Size and Forecast, By Application
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Heart Lung Machine Market
7.2.8.1. Market Size and Forecast, By Component
7.2.8.2. Market Size and Forecast, By Application
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Component
7.3.3. Market Size and Forecast, By Application
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. France Heart Lung Machine Market
7.3.6.1. Market Size and Forecast, By Component
7.3.6.2. Market Size and Forecast, By Application
7.3.6.3. Market Size and Forecast, By End User
7.3.7. Germany Heart Lung Machine Market
7.3.7.1. Market Size and Forecast, By Component
7.3.7.2. Market Size and Forecast, By Application
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Italy Heart Lung Machine Market
7.3.8.1. Market Size and Forecast, By Component
7.3.8.2. Market Size and Forecast, By Application
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Spain Heart Lung Machine Market
7.3.9.1. Market Size and Forecast, By Component
7.3.9.2. Market Size and Forecast, By Application
7.3.9.3. Market Size and Forecast, By End User
7.3.10. UK Heart Lung Machine Market
7.3.10.1. Market Size and Forecast, By Component
7.3.10.2. Market Size and Forecast, By Application
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest Of Europe Heart Lung Machine Market
7.3.11.1. Market Size and Forecast, By Component
7.3.11.2. Market Size and Forecast, By Application
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Component
7.4.3. Market Size and Forecast, By Application
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. China Heart Lung Machine Market
7.4.6.1. Market Size and Forecast, By Component
7.4.6.2. Market Size and Forecast, By Application
7.4.6.3. Market Size and Forecast, By End User
7.4.7. Japan Heart Lung Machine Market
7.4.7.1. Market Size and Forecast, By Component
7.4.7.2. Market Size and Forecast, By Application
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Heart Lung Machine Market
7.4.8.1. Market Size and Forecast, By Component
7.4.8.2. Market Size and Forecast, By Application
7.4.8.3. Market Size and Forecast, By End User
7.4.9. South Korea Heart Lung Machine Market
7.4.9.1. Market Size and Forecast, By Component
7.4.9.2. Market Size and Forecast, By Application
7.4.9.3. Market Size and Forecast, By End User
7.4.10. Australia Heart Lung Machine Market
7.4.10.1. Market Size and Forecast, By Component
7.4.10.2. Market Size and Forecast, By Application
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Heart Lung Machine Market
7.4.11.1. Market Size and Forecast, By Component
7.4.11.2. Market Size and Forecast, By Application
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Component
7.5.3. Market Size and Forecast, By Application
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Heart Lung Machine Market
7.5.6.1. Market Size and Forecast, By Component
7.5.6.2. Market Size and Forecast, By Application
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa Heart Lung Machine Market
7.5.7.1. Market Size and Forecast, By Component
7.5.7.2. Market Size and Forecast, By Application
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Heart Lung Machine Market
7.5.8.1. Market Size and Forecast, By Component
7.5.8.2. Market Size and Forecast, By Application
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Heart Lung Machine Market
7.5.9.1. Market Size and Forecast, By Component
7.5.9.2. Market Size and Forecast, By Application
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Medtronic Plc
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Terumo Corporation
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Getinge AB
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Sorin Group.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. LivaNova PLC
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Fresenius SE And Co. KGaA
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Boston Scientific Corporation
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Cardinal Health, Inc.
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Nipro Corporation
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Asahi Kasei Corporation
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
